- Home
- VSTM vs TRTX Comparison
VSTM vs TRTX Comparison
Compare VSTM & TRTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTM
- TRTX
- Stock Information
- Founded
- VSTM 2010
- TRTX 2014
- Country
- VSTM United States
- TRTX United States
- Employees
- VSTM N/A
- TRTX N/A
- Industry
- VSTM Biotechnology: Pharmaceutical Preparations
- TRTX Real Estate Investment Trusts
- Sector
- VSTM Health Care
- TRTX Real Estate
- Exchange
- VSTM Nasdaq
- TRTX Nasdaq
- Market Cap
- VSTM 662.8M
- TRTX 738.0M
- IPO Year
- VSTM 2012
- TRTX 2017
- Fundamental
- Price
- VSTM $9.92
- TRTX $9.51
- Analyst Decision
- VSTM Strong Buy
- TRTX Buy
- Analyst Count
- VSTM 9
- TRTX 2
- Target Price
- VSTM $13.38
- TRTX $9.50
- AVG Volume (30 Days)
- VSTM 2.9M
- TRTX 580.1K
- Earning Date
- VSTM 11-05-2025
- TRTX 10-28-2025
- Dividend Yield
- VSTM N/A
- TRTX 10.03%
- EPS Growth
- VSTM N/A
- TRTX N/A
- EPS
- VSTM N/A
- TRTX 0.65
- Revenue
- VSTM $2,137,000.00
- TRTX $138,587,000.00
- Revenue This Year
- VSTM $86.06
- TRTX N/A
- Revenue Next Year
- VSTM $395.22
- TRTX $6.91
- P/E Ratio
- VSTM N/A
- TRTX $14.72
- Revenue Growth
- VSTM N/A
- TRTX 216.02
- 52 Week Low
- VSTM $2.40
- TRTX $6.47
- 52 Week High
- VSTM $11.25
- TRTX $9.85
- Technical
- Relative Strength Index (RSI)
- VSTM 66.95
- TRTX 63.40
- Support Level
- VSTM $8.71
- TRTX $9.19
- Resistance Level
- VSTM $11.25
- TRTX $9.85
- Average True Range (ATR)
- VSTM 0.64
- TRTX 0.17
- MACD
- VSTM 0.05
- TRTX 0.01
- Stochastic Oscillator
- VSTM 64.05
- TRTX 60.80
About VSTM Verastem Inc.
Verastem Inc is late-stage development biopharmaceutical company, committed to advancing new medicines for patients battling cancer. Its pipeline is focused on novel anticancer agents that inhibit critical signaling pathways in cancer that promote cancer cell survival and tumor growth, particularly RAF/MEK inhibition and FAK inhibition.
About TRTX TPG RE Finance Trust Inc.
TPG RE Finance Trust Inc is a commercial real estate finance company. It originates, acquires, and manages commercial mortgage loans and other commercial real estate-related debt instruments consisting of first mortgage loans and senior participation interests in first mortgage loans secured by institutional-quality properties in primary and select secondary markets in the United States. The company's objective is to provide attractive risk-adjusted returns to its stockholders over time through cash distributions and capital appreciation. It focuses on directly originating and selectively acquiring floating rate first mortgage loans that are secured by high quality commercial real estate properties undergoing some form of transition and value creation.